John F. Howes

2.8k total citations
81 papers, 2.2k citations indexed

About

John F. Howes is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, John F. Howes has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 19 papers in Cellular and Molecular Neuroscience and 16 papers in Ophthalmology. Recurrent topics in John F. Howes's work include Glaucoma and retinal disorders (13 papers), Neuroscience and Neuropharmacology Research (13 papers) and Ocular Surface and Contact Lens (12 papers). John F. Howes is often cited by papers focused on Glaucoma and retinal disorders (13 papers), Neuroscience and Neuropharmacology Research (13 papers) and Ocular Surface and Contact Lens (12 papers). John F. Howes collaborates with scholars based in United States, United Kingdom and New Zealand. John F. Howes's co-authors include William L. Dewey, Louis S. Harris, Gary D. Novack, Donald L. Wise, Raj K. Razdan, Cynthia Bell, Kathryn Hart, R. S. Crockett, Mark B. Sherwood and Robert Laibovitz and has published in prestigious journals such as Nature, Science and Applied and Environmental Microbiology.

In The Last Decade

John F. Howes

76 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John F. Howes United States 27 677 522 500 406 401 81 2.2k
Santi Spampinato Italy 30 1.4k 2.0× 122 0.2× 1.8k 3.6× 576 1.4× 204 0.5× 197 3.5k
Gary D. Novack United States 36 189 0.3× 1.7k 3.3× 637 1.3× 184 0.5× 282 0.7× 193 4.5k
Frédéric Lallemand Belgium 23 343 0.5× 575 1.1× 298 0.6× 104 0.3× 171 0.4× 37 1.6k
Hiroshi Saito Japan 22 196 0.3× 223 0.4× 410 0.8× 249 0.6× 126 0.3× 91 1.6k
Rami Tamir Israel 21 848 1.3× 86 0.2× 825 1.6× 772 1.9× 162 0.4× 46 2.9k
Young‐Sook Kang South Korea 29 449 0.7× 60 0.1× 1.3k 2.6× 340 0.8× 133 0.3× 81 2.8k
Philip J. Kingsley United States 29 1.1k 1.7× 171 0.3× 683 1.4× 384 0.9× 2.4k 6.0× 73 3.7k
Russell P. Saneto United States 31 560 0.8× 85 0.2× 2.3k 4.6× 337 0.8× 220 0.5× 112 4.1k
Jane E. Shaw United States 21 146 0.2× 47 0.1× 503 1.0× 281 0.7× 450 1.1× 43 2.1k
Nicola Costa Italy 22 334 0.5× 97 0.2× 387 0.8× 160 0.4× 70 0.2× 36 1.3k

Countries citing papers authored by John F. Howes

Since Specialization
Citations

This map shows the geographic impact of John F. Howes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Howes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Howes more than expected).

Fields of papers citing papers by John F. Howes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Howes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Howes. The network helps show where John F. Howes may publish in the future.

Co-authorship network of co-authors of John F. Howes

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Howes. A scholar is included among the top collaborators of John F. Howes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Howes. John F. Howes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howes, John F. & Cynthia Bell. (2007). Talampanel. Neurotherapeutics. 4(1). 126–129. 53 indexed citations
2.
Buchwald, Péter, et al.. (2005). Unified Pharmacogenetics-Based Parent–Metabolite Pharmacokinetic Model Incorporating Acetylation Polymorphism for Talampanel in Humans. Journal of Pharmacokinetics and Pharmacodynamics. 32(3-4). 377–400. 4 indexed citations
3.
Friedlaender, Mitchell H., John F. Howes, R. S. Crockett, & Gary D. Novack. (1998). Comparative efficacy of loteprednol etabonate and prednisolone acetate in the conjunctival provocation test model of ocular allergy. 39(4). 54915. 1 indexed citations
4.
Howes, John F. & Gary D. Novack. (1998). Failure to Detect Systemic Levels, and Effects of Loteprednol Etabonate and its Metabolite, PJ-91, Following Chronic Ocular Administration. Journal of Ocular Pharmacology and Therapeutics. 14(2). 153–158. 21 indexed citations
5.
Abelson, Mark B., et al.. (1998). The Conjunctival Provocation Test Model of Ocular Allergy: Utility for Assessment of an Ocular Corticosteroid, Loteprednol Etabonate. Journal of Ocular Pharmacology and Therapeutics. 14(6). 533–542. 29 indexed citations
6.
Stewart, Robert H., et al.. (1998). Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5 for postoperative inflammation. Journal of Cataract & Refractive Surgery. 24(11). 1480–1489. 57 indexed citations
7.
Dell, Steven J., et al.. (1998). A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis. Journal of Allergy and Clinical Immunology. 102(2). 251–255. 62 indexed citations
8.
Dell, Steven J., et al.. (1997). A Controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Prophylactic Treatment of Seasonal Allergic Conjunctivitis. American Journal of Ophthalmology. 123(6). 791–797. 68 indexed citations
9.
Friedlaender, Mitchell H., et al.. (1997). A Double-masked, Placebo-controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Treatment of Giant Papillary Conjunctivitis. American Journal of Ophthalmology. 123(4). 455–464. 66 indexed citations
10.
Howes, John F., et al.. (1994). Loteprednol Etabonate: Comparison with Other Steroids in Two Models of Intraocular Inflammation. Journal of Ocular Pharmacology and Therapeutics. 10(1). 289–293. 18 indexed citations
11.
Howes, John F., et al.. (1994). The Cross and the Rising Sun, Vol. 2: The British Protestant Missionary Movement in Japan, Korea, and Taiwan, 1865-1945.. Pacific Affairs. 67(1). 102–102. 1 indexed citations
12.
Bartlett, Jimmy D., et al.. (1993). Intraocular Pressure Response to Loteprednol Etabonate in Known Steroid Responders. Journal of Ocular Pharmacology and Therapeutics. 9(2). 157–165. 77 indexed citations
13.
Bartlett, Jimmy D., et al.. (1993). Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis. Current Eye Research. 12(4). 313–321. 36 indexed citations
14.
Hochhaus, Günther, Anna Ratka, Pascal Druzgala, et al.. (1992). Pharmacokinetic Characterization and Tissue Distribution of the New Glucocorticoid Soft Drug Loteprednol Etabonate in Rats and Dogs. Journal of Pharmaceutical Sciences. 81(12). 1210–1215. 30 indexed citations
15.
Howes, John F., et al.. (1987). Buddhism and Christianity in Japan: From Conflict to Dialogue, 1854-1899.. Pacific Affairs. 60(3). 516–516. 1 indexed citations
16.
Dixon, Ross, et al.. (1987). Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist. The Journal of Clinical Pharmacology. 27(3). 233–239. 64 indexed citations
17.
Howes, John F. & F. G. Notehelfer. (1986). American Samurai. Captain L.L. Janes and Japan.. Pacific Affairs. 59(2). 323–323. 1 indexed citations
18.
Howes, John F., et al.. (1982). Pacifism in Japan. The Christian and Socialist Tradition.. Pacific Affairs. 55(2). 315–315. 1 indexed citations
19.
Howes, John F., et al.. (1977). Potential therapeutic agents derived from the cannabinoid nucleus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11. 97–189. 12 indexed citations
20.
Howes, John F., et al.. (1969). BRAIN ACETYLCHOLINE LEVELS AND INHIBITION OF THE TAIL-FLICK REFLEX IN MICE. Journal of Pharmacology and Experimental Therapeutics. 169(1). 23–28. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santi Spampinato Breakdown of academic impact, for papers by Gary D. Novack Breakdown of academic impact, for papers by Frédéric Lallemand Breakdown of academic impact, for papers by Hiroshi Saito Breakdown of academic impact, for papers by Rami Tamir Breakdown of academic impact, for papers by Young‐Sook Kang Breakdown of academic impact, for papers by Philip J. Kingsley Breakdown of academic impact, for papers by Russell P. Saneto Breakdown of academic impact, for papers by Jane E. Shaw Breakdown of academic impact, for papers by Nicola Costa
Rankless by CCL
2026